Elevance Health remains a buy with its strong ... To their fee-paying customers, they offer health products on a full-risk basis and also provide a variety of specialty and other insurance ...

Because this number is lower than its revenue growth, we can see the average customer spent more money each year on the company’s products and services. This quarter, Elevance Health grew its ...

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Thursday. Several other ...

Truist Financial analyst Richard Newitter reiterated a Buy rating on Elevance Health (ELV – Research Report) today and set a price target of ...

Equities researchers at Wolfe Research issued their FY2029 earnings per share (EPS) estimates for Elevance Health in a note issued to investors on Monday, March 31st. Wolfe Research analyst J. Lake ...

In a regulatory filing, Elevance Health (ELV) disclosed that its officers will speak with investors over the next several weeks. During these meetings, they intend to reaffirm the company’s ...

To calculate this metric for Elevance Health, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.12 = US$9.2b ÷ ...

Elevance Health (ELV) shares soared 3.1% in the last trading session to close at $422.04. The move was backed by solid volume with far more shares changing hands than in a normal session.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.